---
schema_version: "secwatch.filing_event.v1"
accession: "0001323885-25-000041"
form_type: "8-K"
ticker: "ATRC"
cik: "0001323885"
company_name: "AtriCure, Inc."
filed_at: "2025-04-29T23:59:59+00:00"
generated_at: "2026-05-23T03:32:13.832926+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# AtriCure Q1 revenue $123.6M (+13.6% YoY); net loss improves to $6.7M from $13.2M

## Summary
- Revenue $123.6M (+13.6% YoY; +14.1% constant currency); U.S. $101.1M (+12.1%), International $22.5M (+20.8%).
- Net loss $6.7M ($0.14 per share) improved from $13.2M ($0.28 per share) a year ago.
- Adjusted EBITDA $8.8M, up from $2.8M in Q1 2024; gross margin 74.9% (+27 bps).
- Growth driven by EnCompass clamp, cryoSPHERE MAX probes, AtriClip Flex-Mini device launches.

## SEC filing metadata
- accession: 0001323885-25-000041
- form_type: 8-K
- ticker: ATRC
- cik: 0001323885
- company_name: AtriCure, Inc.
- filed_at: 2025-04-29T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1323885/000132388525000041/0001323885-25-000041-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1323885/000132388525000041/atrc-20250429.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001323885-25-000041
- JSON: https://secwatch.observer/filing/0001323885-25-000041.json
- Plain text: https://secwatch.observer/filing/0001323885-25-000041.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.